Name: LB Pharmaceuticals Inc (LBRX) Balance Sheet
Creator: FinSpry

LB Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for LB Pharmaceuticals Inc (LBRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	22.98	14.98	21.40
Short-Term Investments	5.02	28.31	0.00
Cash & Short-Term Investments	28.00	43.29	21.40
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.13	0.02	0.08
Total Current Assets	28.88	45.63	21.49
Non-Current Assets
Property, Plant & Equipment (Net)	4.16	0.02	0.00
Other Non-Current Assets	0.50	0.00	0.00
Total Non-Current Assets	4.66	0.02	0.00
Total Assets	33.53	45.66	21.49
Current Liabilities
Accounts Payable	2.32	1.39	0.16
Short-Term Debt	0.49	0.00	0.00
Accrued Liabilities	3.06	0.42	0.31
Other Current Liabilities	5.30	0.00	0.00
Total Current Liabilities	8.11	2.61	0.47
Non-Current Liabilities
Long-Term Debt	3.22	0.00	24.15
Other Non-Current Liabilities	116.76	1.56	18.49
Total Non-Current Liabilities	119.98	77.52	49.84
Total Liabilities	128.09	80.13	43.11
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-104.32	-41.22	-34.95
Accumulated Other Comprehensive Income	0.11	0.27	0.00
Additional Paid-in Capital	9.66	6.47	6.13
Shares Outstanding	22.44	22.44	22.44
Total Stockholders' Equity	-94.55	-34.47	-21.62
Total Liabilities & Equity	33.53	45.66	21.49